Vorinostat: a potent agent to prevent and treat laser-induced corneal haze.

Abstract

Vorinostat is non-cytotoxic and safe for the eye and has potential to prevent laser-induced corneal haze in patients undergoing PRK for high myopia.

Full Text

DOI - Journal of refractive surgery (Thorofare, N.J. : 1995) (DOI)
ProQuest Information and Learning - full-text online
EBSCO - full-text online

Subjects

Similar articles

Flap haze after epithelial debridement and flap hydration for treatment of post-laser in situ keratomileusis striae. (2001-04-26)
Elevated intraocular pressure-induced interlamellar stromal keratitis occurring 9 years after laser in situ keratomileusis. (2011-12-13)
Management of late corneal haze following photorefractive keratectomy. (1995-11-22)
Confocal assessment of the corneal response to intracorneal lens insertion and laser in situ keratomileusis with flap creation using IntraLase. (2006-07-21)
Corneal Inflammation Is Inhibited by the LFA-1 Antagonist, Lifitegrast (SAR 1118). (2012-12-05)
The corneal barrier function in myopic eyes after laser in situ keratomileusis and after photorefractive keratectomy in eyes with haze formation. (1999-06-08)
Corneal haze following PRK with mitomycin C as a retreatment versus prophylactic use in the contralateral eye. (2007-02-02)
Mitomycin C, ceramide, and 5-fluorouracil inhibit corneal haze and apoptosis after PRK. (2005-12-06)
Corneal haze development after PRK is regulated by volume of stromal tissue removal. (1999-01-28)

Authors

Publication date

2012-04-12

Journal

Journal of refractive surgery
J Refract Surg (1081-597X)

Journal topics

Language

Eng.

Copyright

Journal of refractive surgery (Thorofare, N.J. : 1995)

Harry S. Truman Memorial Veterans' Hospital, Columbia, Missouri 65212, USA.

Release reference

J Refract Surg. 2012 Apr;28(4):285-90

Related books

Español | English

© Galenicom 1999-2013